Drug Profile
HIV ribozyme gene therapy - Immusol
Alternative Names: HIVase 1Latest Information Update: 26 Sep 2006
Price :
$50
*
At a glance
- Originator Immusol; University of California, San Diego
- Class Antivirals; Gene therapies; Ribozyme genes
- Mechanism of Action Ribonuclease stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued HIV infections
Most Recent Events
- 26 Sep 2006 Discontinued - Phase-I for HIV infections treatment in USA (Parenteral)
- 10 Jul 2002 This programme is still in active development
- 17 Feb 1999 Phase-I clinical trials for HIV infections treatment in USA (Parenteral)